Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant

American Journal of Gastroenterology

Volumn 93, Issue 11, 1998, Pages 2148-2153

  Min, Albert D ^a   Saxena, Romil ^a   Thung, Swan N ^a   Atillasoy, Evren O ^a   Wolf, David C ^a   Sauter, Bernhard ^a   Schwartz, Myron E ^a   Bodenheimer Jr , Henry C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS TRANSMISSION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; INTERFERONS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032460196     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00611.x     Document Type: Article

References (42)

1. McOmish F., Yap P.L., Dow B.C., et al. Geographical distribution of hepatitis C virus genotypes in blood donors An international collaborative survey . J Clin Microbiol. 32:1994;884-892.
2. Alter M.J., Shapiro C.N., Coleman P.J., Margolis H.S. Viral hepatitis in North America. Nishioka K., Suzuki H., Mishiro S., Oda T. Viral hepatitis and liver diseases Proceedings of the International Symposium on Viral Hepatitis and Liver Diseases . 1994;439-443 Springer-Verlag, Tokyo.
3. Alter M.J. Epidemiology of hepatitis C. Hepatology. 26:1997;62S-65S.
4. Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis. 15:1995;64-69.
5. Nishioka K., Watanabe J., Furuta S., et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 67:1991;429-433.
6. Colombo M., De Franchis R., Del Ninno E., et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:1991;675-680.
7. Poynard T., Aubert A., Lazizi Y., et al. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology. 13:1991;896-901.
8. Leung N.W.Y., Tam J.S., Lai J.Y., et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer. 70:1992;40-44.
9. Kew M.C., Houghton M., Choo Q.L., Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet. 335:1990;873-874.
10. A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma. Cancer. 66:1990;135-139.
11. Nishiguchi S., Kuroki T., Nakatani S., et al. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 346:1995;1051-1055.
12. Tong M.J., El-Farra N.S., Reikes A.R., Co R.L. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 332:1995;1463-1466.
13. Fattovich G., Giustina G., Degos F., et al. Morbidity and mortality in compensated cirrhosis type C A retrospective follow-up study of 384 patients . Gastroenterology. 112:1997;463-472.
14. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the esophagus for bleeding esophageal varices. Br J Surg. 60:1973;646-649.
15. Kaplan G.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;453-481.
16. Ingelfinger J.A., Mosteller F., Thibodeau L.A., Ware J.H. Biostatistics in clinical medicine, 3rd ed. 1994;McGraw-Hill, Inc, New York.
17. Choo Q.-L., Kuo G., Weiner A.J., et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
18. Gilliam J.H. III, Geinsinger K.R., Richter J.E. Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis. Ann Intern Med. 101:1984;794-795.
19. Kiyosawa K., Akahane Y., Nagata A., Furuta S. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol. 79:1984;777-781.
20. Schluger L.K., Bodenheimer H. Jr. Tackling liver cancer with interferon. Lancet. 346:1995;1049-1050.
21. Di Bisceglie A.M., Order S.E., Klein J.L., et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol. 86:1991;335-338.
22. Levrero M., Tagger A., Balsano C., et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol. 12:1991;60-63.
23. Simonetti R.G., Cammà C., Fiorello F., et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med. 116:1992;97-102.
24. Bruix J., Barrera J.M., Calvet X., et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 2:1989;1004-1006.
25. Nalpas B., Driss F., Pol S., et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol. 12:1991;70-74.
26. Yu M.C., Tong M.J., Coursaget P., et al. Prevalence of hepatitis B and C virus markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst. 82:1990;1038-1041.
27. Kew M.C., Yu M.C., Kedda M.-A., et al. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology. 112:1997;184-187.
28. Schwartz M.E., Sung M., Mor E., et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg. 180:1995;596-603.
29. Yamauchi M., Nakahara M., Maezawa Y., et al. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol. 88:1993;39-43.
30. Schluger L.K., Sheiner P.A., Thung S.N., et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 23:1996;971-976.
31. Sheiner P.A., Schluger L.K., Emre S., et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surg. 3:1997;130-136.
32. Mangia A., Vallari D., Di Bisceglie A.M. Use of confirmatory tests for hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol. 43:1994;125-128.
33. Ruiz J., Sangro B., Cuende J.I., et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 16:1992;637-641.
34. Gerber M.A., Shieh Y.S.C., Shim K.S., et al. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol. 141:1992;1271-1277.
35. Pateron D., Ganne N., Trinchet J.C., et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 20:1994;65-71.
36. Tan C.K., Gores G.J., Steers J.L., et al. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc. 69:1994;509-514.
37. Forbes A., Johnson P.J., Williams R. Recombinant human gamma-interferon in primary hepatocellular carcinoma. J Royal Soc Med. 78:1985;826-829.
38. Sachs E., Di Bisceglie A.M., Dusheiko G.M., et al. Treatment of hepatocellular carcinoma with recombinant leucocyte interferon A pilot study . Br J Cancer. 52:1985;105-109.
39. Kasahara A., Hayashi N., Mochizuki K., et al. Risk factors for hepatocellular carcinoma among chronic hepatitis C patients treated with interferon. Hepatology. 24:1996;397A.
40. Okanoue T., Itoh Y., Minami M., et al. Interferon therapy prevents the development of hepatocellular carcinoma in chronic hepatitis C patients. Hepatology. 24:1996;397A.
41. Mizokami M., Hirashima N., Sakakibara K., et al. Development of hepatocellular carcinoma in patients with chronic hepatitis C treated with interferon-alpha. Hepatology. 24:1996;396A.
42. Colombo M. Hepatocellular carcinoma in cirrhotics. Semin Liver Dis. 13:1993;374-383.